Abiopharma

Genelux Corporation to Participate in a Fireside Chat at H.C. Wainwright Global Investment Conference

Bruker - Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock

CareDx - CareDx Issues Comment Letter on Draft LCD Policy

New Form 144 - Health Catalyst, Inc. Filed: 2025-09-02 AccNo: 0001636422-25-000122 Size: 4 KB

Mineralys Therapeutics Announces Proposed Public Offering of Common Stock

Ionis to present at upcoming investor conferences

Bruker Announces Public Offering of $600 Million of Mandatory Convertible Preferred Stock

CareDx Issues Comment Letter on Draft LCD Policy

New Form 144 - Penumbra Inc Filed: 2025-09-02 AccNo: 0001959173-25-005700 Size: 4 KB

Phibro - Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference

Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812)

New Form 144 - Teladoc Health, Inc. Filed: 2025-09-02 AccNo: 0001959173-25-005699 Size: 5 KB

New Form 144 - Apellis Pharmaceuticals, Inc. Filed: 2025-09-02 AccNo: 0001959173-25-005698 Size: 4 KB

New Form 144 - Surgery Partners, Inc. Filed: 2025-09-02 AccNo: 0001969223-25-000694 Size: 6 KB

New Form PRE 14A - Elite Health Systems Inc. Filed: 2025-09-02 AccNo: 0001437749-25-028137 Size: 1 MB